The Wilms' tumor 1 gene (WT1) has been identified as a tumor suppressor gene involved in
the etiology of Wilms' tumor. Approximately 10% of all Wilms' tumors carry mutations in the …

COVID-19 induces haemocytometric changes. Complete blood count changes, including new
cell activation parameters, from 982 confirmed COVID-19 adult patients from 11 European …

The Wilms' tumor 1 gene, WT1 , is homozygously mutated in a subset of Wilms' tumors.
Heterozygous mutations in WT1 give rise to congenital anomalies. During embryogenesis, WT1 …

Studies on the molecular mechanisms underlying neuronal differentiation are frequently
performed using cell lines established from neuroblastomas. In this study we have used mouse …

The use of direct thrombin inhibitors (DTIs) for prophylactic or therapeutic anticoagulation is
increasing because of the predictable bioavailability and short half-life of these DTIs. …

Objectives Pathologic subtyping of tissue biopsies is the gold standard for the diagnosis of
lung cancer (LC), which could be complicated in cases of eg inconclusive tissue biopsies or …

The purpose of this study is to develop a one-step droplet digital RT-PCR (RT-ddPCR) multiplex
assay that allows for sensitive quantification of SARS-CoV-2 RNA with respect to human…

Liquid biopsies have become of interest as minimally invasive ways to monitor treatment
response in lung cancer patients. Circulating tumor DNA (ctDNA) and protein biomarkers are …

Background: Therapeutic drug monitoring (TDM) of infliximab (IFX, Remicade ® ) can aid to
optimize therapy efficacy. Many assays are available for this purpose. However, a reference …

The detection of EGFR-sensitizing and EGFR-resistance mutations in advanced non–small-cell
lung cancer patients is important for the selection and monitoring of EGFR tyrosine-…